Atezolizumab
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| TRIMPACT: Real-World First-Line Atezolizumab Use in Stage IV NSCLC With PD-L1 ≥50% (NCT07279402) | Antalya Training and Research Hospital | 2025-09-15 |
| dTACE-HAIC Combined With Bevacizumab and Atezolizumab for Huge Hepatocellular Carcinoma (NCT06609863) | Sun Yat-sen University | 2024-10-01 |
| The Study Collect Clinical Data From the Treatment of Liver Cancer With New Drugs After 2019 and Integrate Biochemical and Pathological Indicators to Analyze Prognostic Outcomes, Including Overall Survival, Progression-free Survival, and Complications. (NCT07233759) | National Taiwan University Hospital | 2023-01-31 |
Track Atezolizumab automatically
Every clearance here is in the API, with alerts when new ones post.